Skip to main content

Peer Review reports

From: Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice

Original Submission
16 Feb 2020 Submitted Original manuscript
1 Mar 2020 Reviewed Reviewer Report - Rohana Ghani
19 Mar 2020 Reviewed Reviewer Report - Luis Miguel Roman-Pintos
20 Mar 2020 Reviewed Reviewer Report - Musarrat Riaz
31 Mar 2020 Author responded Author comments - Eliza B. Geer
Resubmission - Version 2
31 Mar 2020 Submitted Manuscript version 2
4 Apr 2020 Reviewed Reviewer Report - Musarrat Riaz
29 Apr 2020 Reviewed Reviewer Report - Luis Miguel Roman-Pintos
13 May 2020 Author responded Author comments - Eliza B. Geer
Resubmission - Version 3
13 May 2020 Submitted Manuscript version 3
15 May 2020 Author responded Author comments - Eliza B. Geer
Resubmission - Version 4
15 May 2020 Submitted Manuscript version 4
3 Jun 2020 Author responded Author comments - Eliza B. Geer
Resubmission - Version 5
3 Jun 2020 Submitted Manuscript version 5
12 Jul 2020 Author responded Author comments - Eliza B. Geer
Resubmission - Version 6
12 Jul 2020 Submitted Manuscript version 6
Publishing
14 Jul 2020 Editorially accepted
31 Jul 2020 Article published 10.1186/s12902-020-00595-4

You can find further information about peer review here.

Back to article page